FAM20C, OPN3, TBR1, ANK1, and MYO15A showed AUCs >0.5 for predicting overall survival of GBM patients at 1, 3 and 5 years (Supplementary Figure S3). This evidence concerns the gene ANK1 and glioblastoma.